These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28978205)

  • 21. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
    Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease.
    Meyer A; Bunzemeier H; Hausberg M; Walter M; Roeder N; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2008 Jun; 23(6):1955-60. PubMed ID: 18083761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CKD quality improvement intervention with PCMH integration: health plan results.
    Vassalotti JA; DeVinney R; Lukasik S; McNaney S; Montgomery E; Voss C; Winn D
    Am J Manag Care; 2019 Nov; 25(11):e326-e333. PubMed ID: 31747237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.
    Wyld ML; Lee CM; Zhuo X; White S; Shaw JE; Morton RL; Colagiuri S; Chadban SJ
    Intern Med J; 2015 Jul; 45(7):741-7. PubMed ID: 25944415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
    Chen W; Howard K; Gorham G; Abeyaratne A; Zhao Y; Adegboye O; Kangaharan N; Talukder MRR; Taylor S; Cass A;
    BMC Health Serv Res; 2024 Jul; 24(1):791. PubMed ID: 38982437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical costs of CKD in the Medicare population.
    Honeycutt AA; Segel JE; Zhuo X; Hoerger TJ; Imai K; Williams D
    J Am Soc Nephrol; 2013 Sep; 24(9):1478-83. PubMed ID: 23907508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study.
    Sibbel S; Sato R; Hunt A; Turenne W; Brunelli SM
    BMC Nephrol; 2016 Dec; 17(1):199. PubMed ID: 27955633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.
    Schumock GT; Andress D; E Marx S; Sterz R; Joyce AT; Kalantar-Zadeh K
    Curr Med Res Opin; 2008 Nov; 24(11):3037-48. PubMed ID: 18826748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care costs associated with unrecognized progression to late-stage kidney disease.
    Spencer D; Dunning S; McPheeters J; St Clair Russell J; Hane C
    Am J Manag Care; 2023 Feb; 29(2):e64-e68. PubMed ID: 36811990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?
    Wright DJ; Trucco ME; Zhou J; Wolff C; Holbrook R; Margetta J; El-Chami MF
    Europace; 2024 Jul; 26(7):. PubMed ID: 38890126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study.
    Chen B; Fan VY; Chou YJ; Kuo CC
    BMC Nephrol; 2017 Jan; 18(1):36. PubMed ID: 28122500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs of patients with chronic kidney disease in Germany.
    Gandjour A; Armsen W; Wehmeyer W; Multmeier J; Tschulena U
    PLoS One; 2020; 15(4):e0231375. PubMed ID: 32330140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease: the distribution of health care dollars.
    St Peter WL; Khan SS; Ebben JP; Pereira BJ; Collins AJ
    Kidney Int; 2004 Jul; 66(1):313-21. PubMed ID: 15200439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
    Goncalves GMR; Silva END
    PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.